Autor: |
Qing, Zhao, Mubarak, Almutairi, Arun, Tailor, Adam, Lister, Nicolas, Harper, James, Line, Xiaoli, Meng, Jirawat, Pratoomwun, Kanoot, Jaruthamsophon, Chonlaphat, Sukasem, Yonghu, Sun, Lele, Sun, Monday O, Ogese, David J, MacEwan, Munir, Pirmohamed, Jianjun, Liu, David A, Ostrov, Hong, Liu, Furen, Zhang, Dean J, Naisbitt |
Rok vydání: |
2020 |
Předmět: |
|
Zdroj: |
The Journal of investigative dermatology. 141(10) |
ISSN: |
1523-1747 |
Popis: |
HLA-B∗13:01 is associated with dapsone (DDS)-induced hypersensitivity, and it has been shown that CD4+ and CD8+ T cells are activated by DDS and its nitroso metabolite (nitroso dapsone [DDS-NO]). However, there is a need to define the importance of the HLA association in the disease pathogenesis. Thus, DDS- and DDS-NO‒specific CD8+ T-cell clones (TCCs) were generated from hypersensitive patients expressing HLA-B∗13:01 and were assessed for phenotype and function, HLA allele restriction, and killing of target cells. CD8+ TCCs were stimulated to proliferate and secrete effector molecules when exposed to DDS and/or DDS-NO. DDS-responsive and several DDS-NO‒responsive TCCs expressing a variety of TCR sequences displayed HLA class-I restriction, with the drug (metabolite) interacting with multiple HLA-B alleles. However, activation of certain DDS-NO‒responsive CD8+ TCCs was inhibited with HLA class-II block, with DDS-NO binding to HLA-DQB1∗05:01. These TCCs were of different origin but expressed TCRs displaying the same amino acid sequences. They were activated through a hapten pathway; displayed CD45RO, CD28, PD-1, and CTLA-4 surface molecules; secreted the same panel of effector molecules as HLA class-I‒restricted TCCs; but displayed a lower capacity to lyse target cells. To conclude, DDS and DDS-NO interact with a number of HLA molecules to activate CD8+ TCCs, with HLA class-II‒restricted CD8+ TCCs that display hybrid CD4‒CD8 features also contributing to the promiscuous immune response that develops in patients. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|